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ale, yes, n (%)
ge, years
ymptom duration, years
moking, yes, n (%)
moking pack year, years
revious exacerbation,a yes, n (%)
umber of exacerbation
umber of controller medications
MI
EV1 %Pred.
VC %Pred.
ost-BD FEV1/FVC ratio
topy, yes, n (%)
topy index
umber of eosinophil
ymptom score
A, elderly asthma; NEA, non-elderl
olume in 1 s; FVC, Pred.%, % of pre
ata indicate means  SDs. A statis
a During previous one year.Methods: We performed principal component analysis (PCA) using 2067 asthmatics (434 EA and
1633 NEA) from the Korean Cohort for Reality and Evolution of adult Asthma (COREA). EA was
defined as asthmatics with the chronological age of 65 or more and eleven clinical variables
measured at enrollment were used for PCA; symptom score, symptom duration, number of
exacerbation during previous one year, smoking pack year, number of controller medications,
body mass index, predicted % of FEV1, predicted % FVC, post-bronchodilator FEV1/FVC ratio,
atopy index and number of eosinophils in peripheral blood.
Results: PCA of all asthmatics showed that EA and NEA were distinctly separated by the first
and second principal component on the plot of individual asthmatics according to their scores.
For further analysis, we divided all asthmatics into the EA and the NEA group and performed
PCA again in each group. The first four principal components with eigenvalues  1.0 were iden-
tified in both groups and they explained 55.5% of the variance in the EA group and 52.4% in the
NEA group respectively. Clinical variables showed distinctly different patterns of loading on
the first four principal components between the EA and the NEA group.
Conclusion: EA and NEA have different compositional patterns underlying their clinical vari-
ables. These observations helped in understanding the differences between EA and NEA from
the integrated view covering various clinical aspects.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Elderly asthma usually refers to asthma in people aged 65
years and over. Aging is accompanied with changes in res-
piratory physiology [1,2] and immunology [3,4]. Therefore,
elderly asthmatics (EA) is thought to be distinct from non-
elderly (i.e. young) asthmatics (hereafter NEA) and the
differences cannot be fully explained by chronological age
alone. Compared to patients with NEA, patients with EA
have higher rates of airway hyperresponsiveness, more se-
vere asthma, lower prevalence of atopy, and are more
difficult to control with corticosteroids [5e9]. Although.
EA
n Z 434
220 (50.7)
70.2  4.2
11.8  14.9
148 (34.1)
13.9  22.8
119 (27.4)
0.6  1.5
0.7  0.9
24.7  3.2
75.0  24.9
82.2  19.9
66.8  13.2
137 (31.5)
4.7  13.8
226.5  240.
5.7  3.0
y asthma; BMI, body mass index (
dicted value of a forced vital cap
tical significant value (P < 0.05) ithese observations are helpful to differentiate EA from
NEA, understanding the contribution of multiple clinical
variables as a mixture to EA is more challenging. To achieve
this purpose, it is desirable to use an indicator that can
reflect EA as a complex mixture rather than the sum of
individual clinical variables.
Principal component analysis (PCA) is a statistical
technique that analyzes a data set in which observations
are described by several inter-correlated quantitative
dependent variables [10]. Its goal is to extract the impor-
tant information from a data set, to represent it as a set of
new orthogonal variables called principal components, andNEA P-value
n Z 1633
736 (45.1) 0.052
44.2  13.0 <0.001
7.8  10.0 <0.001
350 (21.4) <0.001
7.1  14.0 <0.001
547 (33.5) 0.016
0.9  2.0 <0.001
0.7  0.9 0.989
23.7  3.4 <0.001
81.6  20.2 <0.001
89.6  17.5 <0.001
74.4  11.9 <0.001
992 (60.7) <0.001
10.7  17.9 <0.001
1 309.4  339.3 0.558
9.5  2.8 <0.001
kg/m2); FEV1, Pred.%, % of predicted value of a forced expiratory
acity; Post-BD, post-bronchodilator.
s shown in bold print.
Figure 1 Results of PCA for all asthmatics. (A) A plot of in-
dividual asthmatics according to their scores of the first and
second principal component. Black dots represent elderly
asthma and grey dots represent non-elderly asthma. (B) A
circle of correlations and loadings of clinical variables for the
first and second principal component. Abbreviations are: FVCp,
predicted % forced vital capacity; FEV1p, predicted % of FEV1;
FEV1_FVC, post-bronchodilator FEV1/FVC ratio; Sx_Score,
symptom score; Atopy_Index, atopy index; Blood_Eo, number
of eosinophils in peripheral blood; No_Exa, number of exac-
erbation; No_Cont, number of controller medications; Sx_Dur,
symptom duration; Smoke_PY, smoking pack year; BMI, body
mass index.
Differences between asthma in young and elderly 1511to display the pattern of similarity of the observations and
of the variables as points in maps [11]. Using PCA, several
clinical variables can be reduced to one or fewer compo-
nents based on the correlations among the individual
clinical variables. In addition to data reduction, PCA can
identify compositional patterns that can be used to
examine the similarities and differences [11].
In this study, we hypothesized that clinical variables
used commonly in practice are differently reduced to un-
derlying similar characteristics in a multidimensional space
between EA and NEA. To test our hypothesis, PCA was
performed using a cross sectional data set obtained from
the Cohort for Reality and Evolution of Adult Asthma in
Korea (COREA) [12].
Methods
Study population
Asthmatics enrolled in the COREA were recruited by aller-
gists or pulmonologists from 11 referral centers in diverse
areas of Korea [12]. The diagnosis of asthma was made
according to the criteria proposed by the Global Initiative
for Asthma (GINA) with symptoms including episodic
coughing and shortness of breath lasting more than 3
months, plus a positive bronchodilator response [>12%
improvement in forced expiratory volume in 1 s (FEV1) after
administration of 180 mg of albuterol by a metered-dose
inhaler] or a positive methacholine bronchial provocation
test [provocative concentration of methacholine causing a
20% reduction in FEV1  16 mg/mL] [13]. At enrollment,
asthmatics were in a stable state with regular medications.
Exclusion criteria were destroyed lungs or bronchiectasis on
simple chest X-ray and history of lung resection. However,
the COREA did not completely exclude smoking asthmatics
if their diagnosis was soundly confirmed when they were
enrolled [12]. EA was defined as asthmatics with the chro-
nological age of 65 years or more. Written informed con-
sents were obtained from the study participants and the
COREA protocol was approved by the Seoul National Uni-
versity Hospital Institutional Review Board.
Clinical variables
Eleven clinical variables in the COREA database were used
for PCA: symptom score, symptom duration, number of
exacerbation during the previous year, smoking pack year,
number of controller medications, bodymass index (BMI, kg/
m2), predicted % of FEV1, predicted % forced vital capacity
(FVC), post-bronchodilator FEV1/FVC ratio, atopy index, and
number of eosinophils in peripheral blood. Symptom score
[1e5 scale: most days a week (1), several days a week (2), a
few days a week (3), only with chest infections (4), not at all
(5)] was based on responses to four statements: “Over the
last year, I have coughed”; “Over the last year, I have
brought up sputum”; “Over the last year, I have had short-
ness of breath”; and “Over the last year, I have had attacks
of wheezing”. An asthma exacerbation was defined by any
one of the following criteria: use of systemic corticosteroids
or an increase from a stable maintenance dose for at least
three days, and asthma-specific unscheduled visits andemergency department visits or hospitalization. Number of
asthma exacerbation was assessed by the careful review of
medical records during 1 year prior to enrollment. Controller
medications included inhaled corticosteroid with or without
long-acting beta-2 agonist, leukotriene modifier, sustained
release theophylline, oral corticosteroid and anti-IgE anti-
body as suggested by the current guideline [13]. Skin prick
testing with 11 common aeroallergens (Dermatophagoides
1512 H.-W. Park et al.pteronyssinus, Dermatophagoides farinae, dog fur, cat fur,
Aspergillus, Alternaria, tree pollen mixture, grass pollen
mixture, mugwort, ragweed and cockroach; Allergopharma,
Reinbek, Germany) was performed. The atopy index was
calculated by summing the wheal size of the allergens. The
number of eosinophils in peripheral blood was measured
using an automated blood cell analyzer. We confirmed that
clinical variables of subjects did not differ significantly be-
tween hospitals which they were enrolled in.
Statistical analysis
PCA was performed using the 11 clinical variables. PCA is a
type of multivariate analysis that reveals the internal
structure of the data that best explains the variance in the
data [11]. PCA was implemented using the FactoMineR
(Factor analysis and data Mining with R, www.cran.r-
project.org/web/packages/FactoMineR/index.html) pack-
age [14]. In the FactoMineR, the solution maximizing the
variance of projected points is kept. The FactoMineR
method does not apply any rotation to keep optimal prop-
erty of the maximization of variance of the projection
points, although rotational algorithms help improve the
interpretability of the principal components. Loadings (i.e.,
standard coordinates) are not given by the FactoMineR and
they were presently calculated by dividing the coordinates
of the variable on a dimension by this dimension’s eigen-
value’s square root. Only components with an eigenvalue
above 1.0 were retained in the solution. When the variables
are entirely represented by only two components, the sum
of the squared loadings is equal to one. In this case, the
points will be positioned on a circle which is called the
circle of correlations. When more than two components are
required to represent the variable perfectly, the points
are positioned inside the circle of correlations. The closer
a point is to the circle of correlations, the better we can
reconstruct this variable from the two components. Mean-
while, the closer to the center of the plot a point is, the lessTable 2 Factor loadingsa and cumulative variance of the first fou
asthma group.
Variables Eldery asthma
PC1 PC2
FEV1 predicted % 0.570 0.077
FVC predicted % 0.461 0.109
Post-BD FEV1/FVC ratio 0.457 0.109
Number of controller medications 0.083 0.620
Number of exacerbations during
previous 1 year
0.103 0.555
Smoking (pack year) 0.278 0.154
Symptom duration 0.161 0.003
Body mass index 0.201 0.284
Symptom score 0.120 0.011
Atopy index 0.253 0.294
Number of eosinophil in peripheral blood 0.112 0.310
Percent variance explained by factor 23.8 11.8
Cumulative explained variance 23.8 35.6
PC, principal component; Post-BD, post-bronchodilator.
a Values represent coefficients of correlation between variables andimportant it is for the two components. All analyses were
performed with R version 2.15.2 (www.r-project.org).
Results
A total of 2067 asthmatics (434 EA and 1633 NEA) were
enrolled for analysis. The baseline characteristics are
summarized in Table 1. PCA of all asthmatics identified the
first four principal components with eigenvalues  1.0 and
together they explained 53.5% of the variance. Fig. 1
showed a plot of individual asthmatics according to their
scores for the first and second principal component and a
circle of correlations showing loadings of clinical variables
for the first and second principal components. EA and NEA
were distinctly separated by the first and second principal
component on the plot of individual asthmatics according
to their scores. For further analysis, we divided all asth-
matics into the EA and the NEA group and performed PCA
using 11 clinical variables, the same as the first PCA per-
formed in all asthmatics. In both groups, the first four
principal components with eigenvalues  1.0 were identi-
fied and they explained 55.5% of the variance in the EA
group and 52.4% in the NEA group. Clinical variables showed
different patterns of loading on the first four principal
components between the EA and the NEA group (Table 2). A
factor loading of 0.4 or greater (or 0.4) within a
particular principal component was used as the cut-off for
practical significance, given that the sample size was over
200 [15]. A circle of correlations and plot of loadings of
clinical variables for the first and the second principal
component is shown in Fig. 2. Variables related with lung
function (FEV1 predicted%, FVC predicted%, and post-
bronchodilator FEV1/FVC ratio) were mainly loaded to the
first principal component and closer to circle of correlation
in both groups, which suggested that we could reconstruct
these variables from the first principal component in the EA
group as well as in the NAE group. However, BMI, atopy
index, and number of exacerbations showed oppositer principal components in the elderly asthma and non-elderly
Non-elderly asthma
PC3 PC4 PC1 PC2 PC3 PC4
0.078 0.009 0.603 0.246 0.106 0.109
0.212 0.336 0.480 0.232 0.083 0.414
0.212 0.336 0.458 0.007 0.150 0.315
0.093 0.044 0.127 0.202 0.474 L0.451
0.305 0.184 0.179 0.073 0.628 0.213
L0.518 0.071 0.248 0.380 0.187 0.213
0.442 0.349 0.225 0.204 0.438 0.383
0.417 0.246 0.062 0.480 0.107 0.153
0.004 0.651 0.127 0.334 0.113 0.029
0.315 0.242 0.106 L0.476 0.190 0.316
0.289 0.367 0.047 0.288 0.225 0.382
10.5 9.4 21.3 11.1 10.5 9.5
46.1 55.5 21.3 32.4 42.9 52.4
components. Practical significance is shown in bold print.
Figure 2 Circle of correlations and plot of loadings of the
variables with the first and second principal component for
elderly asthmatics (A) and non-elderly asthmatics (B). Abbre-
viations are: FVCp, predicted % forced vital capacity; FEV1p,
predicted % of FEV1; FEV1_FVC, post-bronchodilator FEV1/FVC
ratio; Sx_Score, symptom score; Atopy_Index, atopy index;
Blood_Eo, number of eosinophils in peripheral blood; No_Exa,
number of exacerbation; No_Cont, number of controller med-
ications; Sx_Dur, symptom duration; Smoke_PY, smoking pack
year; BMI, body mass index.
Differences between asthma in young and elderly 1513directions of loading to the first and the second principal
component between the EA and the NEA group. Number of
controller medications and number of exacerbations were
closer to the center of circle in the NAE group than in the EA
group, which implied that those clinical variables were less
important for the first two principal components in the NAE
group compared to the EA group.
Discussion
One of the goals of PCA is to analyze the structure of the
observations and the variables [11]. In the present study, 11clinical variables were reduced to four major components
in all asthmatics, which explained 53.5% of the variability
using PCA. Consistent with our a priori assumption, we
found that EA and NEA were differently located in a two-
dimensional space made by the first and the second prin-
cipal components. Subsequent PCA performed in the EA and
the NEA group separately showed that the 11 clinical vari-
ables were differently loaded to the first four principal
components between two groups, which suggested that
unmeasured latent variables underlying EA and NEA might
distinctively differ.
EA is a heterogeneous disorder with complex patho-
physiologic mechanisms [16]. Thus, comparisons between
EA and NEA should be done from the integrated view
covering various clinical aspects. Focusing a few clinical
variables, we could easily find differences between EA and
NEA, as shown in Table 1. Our findings were similar to those
shown by previous reports [5e9]. However, we need to
understand the contribution of multiple clinical variables as
a mixture when we tried to search the difference between
EA and NEA. For this reason, we used PCA, because PCA
enables us to identify the compositional patterns that un-
derlie EA and NEA and to examine differences based on
those patterns. In the present study, based on the patterns
of factor loadings, we could summarize the first four prin-
cipal components identified in the EA group as follows:
airway obstruction (the first component), asthma control
(the second component), risk factors (the third compo-
nent), and symptom severity (the fourth component).
Likewise, airway obstruction and asthma control were
identified as important components in NEA, while we could
not characterize the second and the fourth principal
component in the NEA group as we did in the EA group due
to the heterogeneity in clinical variables with significant
factor loadings. Considering clinical variables related with
lung function were well constructed from the first principal
component in both groups, airway obstruction might be the
most important feature for the characterization of EA and
NEA. This finding was anticipated and consistent with what
we already knew.
However, heterogeneous patterns of loadings found in
other clinical variables suggested that clinical variables
other than lung function played different roles for the
characterization of EA and NEA. Body mass index (BMI) can
be a good example. For the first and the second principal
component, BMI in the EA group showed the opposite
loading patterns to the NEA group. So far, numerous re-
ports consistently have suggested that obesity increase
asthma severity [17e19]. However, only children or adult
less than 60 years of age were included in those studies
and thus we are not sure that same relations may be found
in EA. Recently, it was reported that an association be-
tween obesity and asthma was significantly modified
by age of asthma onset [20]. Moreover, the spirometric
values decreased significantly in proportion to the in-
crease of BMI in asthmatics but there was no negative
correlation between BMI and FEV1 in the asthmatics over
60 years of age. [21]. Taken together, although BMI is an
important variable characterizing EA and NEA (as their
values of factor loadings were significant; 0.417 for EA and
0.480 for NEA), the way of its contribution to EA may differ
for NEA.
1514 H.-W. Park et al.Loading pattern on the first principal component of
atopy index in the EA group was opposite to that of atopy
index in the NEA group. Moreover, atopy index in the EA
group showed no significant values of factor loadings on the
four principal components. For many years, EA was char-
acterized by non-atopic [22]. However, recent data from
large populations have demonstrated that EA are also
atopic [23,24]. Interestingly, it was reported that smoking
attenuated the age-related decrease in IgE levels and
maintained eosinophilic inflammation [25]. Likewise, atopy
index and smoking pack year in the EA group showed same
loading patterns on the first principal component, while
loading patterns of atopy index and smoking pack year on
the first and second principal components were opposite in
the NEA group. Taken together, our results suggested that
the role of atopy in the pathogenesis of EA should be
assessed in the context of correlations with other clinical
variables including smoking.
In the present study, we identified four principal com-
ponents underlying EA and NEA using PCA and found that 11
clinical variables showed distinctly different patterns of
loading on the first four principal components between the
EA and the NEA group. Our observations helped us to un-
derstand differences between EA and NEA from the inte-
grated view covering various clinical aspects. However, it
should be kept in mind that our findings may only be
applicable to populations of Asian origin. We hope that the
results of the current study will be reproduced in another
sample set of elderly asthmatics.Acknowledgement
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